Funding from
Renenue, per update:
USA, U$500,000/mth = $6m a year, frm IDTF, minimal,
( not inclu any from militay hospital deals, forget hygea for now )
UK, 10 hospitals, €256k, U$300,000/yr, $3m a year, $250000 a month
(i expect another 10 more hospitals to siign up before christmas)
Total revenue, approx u$750,000 a month, sufficient to *break even*
If not, CEO loan is the back up.
I asked a friend (who bought spat 40c) to buy double that lot at 12c on open.
His av investment price is 21.3c.
Good buy.
GLTAH
.
- Forums
- ASX - By Stock
- Ann: US Listing Update
Funding fromRenenue, per update:USA, U$500,000/mth = $6m a year,...
-
- There are more pages in this discussion • 33 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add GMV (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online